Piscataqua Savings Bank Finch Therapeutics Group, Inc. Transaction History

Piscataqua Savings Bank

  • $117 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022
SELL
$8.95 - $16.88 $3,579 - $6,752
-400 Closed
0 $0
Q1 2021

Apr 20, 2021
BUY
$15.54 - $21.32 $6,216 - $8,528
400 New
400 $6,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $575M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Piscataqua Savings Bank Portfolio

Follow Piscataqua Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piscataqua Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Piscataqua Savings Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email